SIEGALL CLAY B 4
4 · Immunome Inc. · Filed May 21, 2024
Insider Transaction Report
Form 4
Immunome Inc.IMNM
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2024-05-20$13.91/sh+79,566$1,106,524→ 399,202 total - Purchase
Common Stock
2024-05-21$13.78/sh+20,434$281,548→ 419,636 total
Footnotes (2)
- [F1]The weighted average purchase price for the transaction report was $13.907,and the range of prices were between $13.77 and $13.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]The weighted average purchase price for the transaction report was $13.7784, and the range of prices were between $13.62 and $13.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.